Boditech Med바디텍메드
206640 · KOSDAQ · ₩206640 · 바디텍메드
₩8,400▼ ₩160 (1.87%)End-of-day · Oct 30, 2026 · End-of-day prices.
Income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | ₩162B | ₩138B | ₩134B | ₩118B | ₩158B |
| Cost of sales | ₩66B | ₩56B | ₩53B | ₩47B | ₩59B |
| Gross profit | ₩96B | ₩82B | ₩81B | ₩71B | ₩98B |
| Operating income | ₩29B | ₩26B | ₩28B | ₩25B | ₩52B |
| Net income | ₩24B | ₩27B | ₩27B | ₩25B | ₩47B |
| Net income to shareholders | ₩24B | ₩27B | ₩27B | ₩25B | ₩47B |
Balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Total assets | ₩282B | ₩255B | ₩228B | ₩196B | ₩192B |
| Current assets | ₩123B | ₩136B | ₩139B | ₩117B | ₩131B |
| Cash and equivalents | ₩20B | ₩48B | ₩42B | ₩26B | ₩39B |
| Total liabilities | ₩37B | ₩32B | ₩30B | ₩21B | ₩31B |
| Current liabilities | ₩23B | ₩27B | ₩27B | ₩16B | ₩27B |
| Borrowings | ₩15B | ₩8.8B | ₩9.4B | ₩7.3B | ₩5.2B |
| Total equity | ₩244B | ₩223B | ₩197B | ₩175B | ₩161B |
| Shareholders' equity | ₩231B | ₩210B | ₩186B | ₩164B | ₩151B |
Cash flow
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Cash from operations | ₩22B | ₩25B | ₩34B | ₩23B | ₩50B |
| Capital spending | ₩33B | ₩11B | ₩4.6B | ₩15B | ₩18B |
| Free cash flow | −₩11B | ₩13B | ₩30B | ₩7.8B | ₩32B |
| Dividends paid | ₩3.3B | ₩4.4B | ₩3.3B | ₩4.3B | ₩4.6B |
Consolidated where available. Amounts in won.
Also known as: Boditech Med / 바디텍메드 / 206640 / KRX:206640
Source: KRX statistical information